Bristol-Myers Squibb Company Capital Reinvestment Ratio
Bristol-Myers Squibb Company capital reinvestment ratio. Bristol-Myers Squibb Company (BMY) has a Capital Reinvestment Ratio of 0.09x as of June 2026, meaning it reinvests 0% of its operating cash flow ($3.39 Billion) in capital expenditures ($305.00 Million). Check Bristol-Myers Squibb Company (BMY) total reinvestment rate to assess the company's total reinvestment commitment from operating cash flow.
Capital Reinvestment Ratio
Operating Cash Flow
Capital Expenditures
Data as of
Capital Reinvestment Ratio of Bristol-Myers Squibb Company (1989–2025)
Capital reinvestment ratio of Bristol-Myers Squibb Company from 1989 to 2025. This chart tracks Bristol-Myers Squibb Company's Capital Reinvestment Ratio across 37 annual periods. Also explore how fast is Bristol-Myers Squibb Company growing its equity to track the company's year-over-year net asset growth rate.
Bristol-Myers Squibb Company Capital Reinvestment Ratio by Year (1989–2025)
Bristol-Myers Squibb Company capital reinvestment ratio by year from 1989 to 2025. For the full cash flow conversion analysis, see Bristol-Myers Squibb Company cash flow conversion.
| Year | Reinvestment Ratio | Operating CF (USD) | Capital Expenditures | YoY Change |
|---|---|---|---|---|
| 2025 | 0.09x | $14.16 Billion | $1.31 Billion | ▲ +12.7% |
| 2024 | 0.08x | $15.19 Billion | $1.25 Billion | ▼ -5.8% |
| 2023 | 0.09x | $13.86 Billion | $1.21 Billion | ▲ +1.9% |
| 2022 | 0.09x | $13.07 Billion | $1.12 Billion | ▲ +42.5% |
| 2021 | 0.06x | $16.21 Billion | $973.00 Million | ▲ +12.0% |
| 2020 | 0.05x | $14.05 Billion | $753.00 Million | ▼ -48.3% |
| 2019 | 0.10x | $8.07 Billion | $836.00 Million | ▼ -23.0% |
| 2018 | 0.13x | $7.07 Billion | $951.00 Million | ▼ -32.7% |
| 2017 | 0.20x | $5.28 Billion | $1.05 Billion | ▼ -49.7% |
| 2016 | 0.40x | $3.06 Billion | $1.22 Billion | ▲ +2.0% |
| 2015 | 0.39x | $2.10 Billion | $820.00 Million | ▲ +133.1% |
| 2014 | 0.17x | $3.15 Billion | $526.00 Million | ▲ +10.3% |
| 2013 | 0.15x | $3.54 Billion | $537.00 Million | ▲ +91.9% |
| 2012 | 0.08x | $6.94 Billion | $548.00 Million | ▲ +4.1% |
| 2011 | 0.08x | $4.84 Billion | $367.00 Million | ▼ -19.7% |
| 2010 | 0.09x | $4.49 Billion | $424.00 Million | ▼ -47.4% |
| 2009 | 0.18x | $4.07 Billion | $730.00 Million | ▼ -29.3% |
| 2008 | 0.25x | $3.71 Billion | $941.00 Million | ▼ -5.1% |
| 2007 | 0.27x | $3.15 Billion | $843.00 Million | ▼ -29.8% |
| 2006 | 0.38x | $2.08 Billion | $793.00 Million | ▼ -9.0% |
| 2005 | 0.42x | $1.84 Billion | $768.00 Million | ▲ +64.2% |
| 2004 | 0.25x | $3.18 Billion | $809.00 Million | ▼ -9.6% |
| 2003 | 0.28x | $3.51 Billion | $990.00 Million | ▼ -77.5% |
| 2002 | 1.25x | $945.00 Million | $1.18 Billion | ▲ +560.5% |
| 2001 | 0.19x | $5.40 Billion | $1.02 Billion | ▲ +49.6% |
| 2000 | 0.13x | $4.65 Billion | $589.00 Million | ▼ -24.6% |
| 1999 | 0.17x | $4.22 Billion | $709.00 Million | ▼ -19.4% |
| 1998 | 0.21x | $3.78 Billion | $788.00 Million | ▼ -32.7% |
| 1997 | 0.31x | $2.48 Billion | $767.00 Million | ▲ +36.1% |
| 1996 | 0.23x | $2.64 Billion | $601.00 Million | ▲ +10.9% |
| 1995 | 0.21x | $2.50 Billion | $513.00 Million | ▼ -17.6% |
| 1994 | 0.25x | $2.30 Billion | $573.00 Million | ▲ +12.7% |
| 1993 | 0.22x | $2.58 Billion | $570.00 Million | ▼ -30.8% |
| 1992 | 0.32x | $2.03 Billion | $647.00 Million | ▼ -6.8% |
| 1991 | 0.34x | $1.83 Billion | $628.00 Million | ▲ +16.9% |
| 1990 | 0.29x | $1.75 Billion | $513.00 Million | ▼ -37.2% |
| 1989 | 0.47x | $1.19 Billion | $555.00 Million | — |